I propose to investigate determinants of substrate specificity of several protein kinases that mediate the actions of the intracellular second messengers cAMP, cGMP, and calcium ion. Synthetic peptides and purified proteins will be used as model substrates and inhibitors in in vitro enzymological studies of purified cAMP-dependent cGMP-dependent, and multifunctional Ca2+/calmodulin-dependent protein kinases. Synthetic oligopeptides corresponding to amino acid sequences in the active portion of the heat-stable inhibitor protein of cAMP-dependent protein kinase will be used to investigate the specificity of this inhibitor for the two cyclic nucleotide-dependent protein kinases. An active catalytic fragment of cGMP-dependent protein kinase will be generated from the holoenzyme by limited proteolysis. The activity of this fragment will be compared to that of intact cGMP-dependent protein kinase to investigate the influence of the regulatory domain of the holoenzyme on the interaction of peptide substrates and inhibitors at the active site. In other studies, I will characterize the phosphorylation of cardiac muscle C-protein, a component of the thick-filament, by cGMP-dependent, cAMP-dependent, and Ca2+/calmodulin-dependent protein kinases with respect to kinetic parameters, stoichiometries and primary structure at sites of phosphorylation. Results will allow development of a method for mapping site-specific phosphorylation of C-protein from intact tissues under physiological conditions in which different protein kinases are activated. Knowledge of phosphorylation sites in C-protein will also aid structure-function studies of purified C-protein selectively phosphorylated by different protein kinases. The potential presence of C-protein or C-protein-like immunoreactivity in tissues rich in smooth muscle will be investigated. Immunoreactive smooth muscle proteins will be studied as potential substrates of protein kinases that may mediate relaxation of smooth muscle in response to physiological stimuli, particularly the cGMP-dependent protein kinase. These studies should provide new information about the molecular details that dictate the substrate specificity determinants of cAMP-dependent, cGMP-dependent, and Ca2+/calmodulin-dependent protein kinases. An increased understanding of the differences in the active sites of these protein kinases may allow the development of selective inhibitors of each enzyme. Such reagents would be useful pharmacological tools in the study of the physiological roles of protein kinases and their substrates.

Agency
National Institute of Health (NIH)
Institute
National Institute of General Medical Sciences (NIGMS)
Type
Research Project (R01)
Project #
5R01GM028144-08
Application #
3275429
Study Section
Physiological Chemistry Study Section (PC)
Project Start
1980-07-01
Project End
1989-06-30
Budget Start
1987-07-01
Budget End
1988-06-30
Support Year
8
Fiscal Year
1987
Total Cost
Indirect Cost
Name
Emory University
Department
Type
Schools of Medicine
DUNS #
042250712
City
Atlanta
State
GA
Country
United States
Zip Code
30322
Glass, D B; Trewhella, J; Mitchell, R D et al. (1995) Conformationally constrained analogs of protein kinase inhibitor (6-22)amide: effect of turn structures in the center of the peptide on inhibition of cAMP-dependent protein kinase. Protein Sci 4:405-15
Glass, D B; Feller, M J; Levin, L R et al. (1992) Structural basis for the low affinities of yeast cAMP-dependent and mammalian cGMP-dependent protein kinases for protein kinase inhibitor peptides. Biochemistry 31:1728-34
Glass, D B; Robertson, D G; Xu, T S et al. (1991) Chemical synthesis, initial conformational studies, and activity of rat steroidogenesis activator peptide and a truncated analog. Endocr Res 17:307-26
Glass, D B; Cheng, H C; Mende-Mueller, L et al. (1989) Primary structural determinants essential for potent inhibition of cAMP-dependent protein kinase by inhibitory peptides corresponding to the active portion of the heat-stable inhibitor protein. J Biol Chem 264:8802-10
Reed, J; De Ropp, J S; Trewhella, J et al. (1989) Conformational analysis of PKI(5-22)amide, the active inhibitory fragment of the inhibitor protein of the cyclic AMP-dependent protein kinase. Biochem J 264:371-80
Katz, B M; Lundquist, L J; Walsh, D A et al. (1989) Synthesis, characterization and inhibitory activities of (4-N3[3,5-3H]Phe10)PKI(6-22)amide and its precursors: photoaffinity labeling peptides for the active site of cyclic AMP-dependent protein kinase. Int J Pept Protein Res 33:439-45
Glass, D B; Lundquist, L J; Katz, B M et al. (1989) Protein kinase inhibitor-(6-22)-amide peptide analogs with standard and nonstandard amino acid substitutions for phenylalanine 10. Inhibition of cAMP-dependent protein kinase. J Biol Chem 264:14579-84
Lamb, N J; Fernandez, A; Conti, M A et al. (1988) Regulation of actin microfilament integrity in living nonmuscle cells by the cAMP-dependent protein kinase and the myosin light chain kinase. J Cell Biol 106:1955-71
Bhatnagar, D; Glass, D B; Roskoski Jr, R et al. (1988) Synthetic peptide analogues differentially alter the binding affinities of cyclic nucleotide dependent protein kinases for nucleotide substrates. Biochemistry 27:1988-94
Aswad, D W; Johnson, B A; Glass, D B (1987) Modification of synthetic peptides related to lactate dehydrogenase (231-242) by protein carboxyl methyltransferase and tyrosine protein kinase: effects of introducing an isopeptide bond between aspartic acid-235 and serine-236. Biochemistry 26:675-81

Showing the most recent 10 out of 18 publications